AURA

Aura Biosciences

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Healthcare

industry

Biotechnology

Exchange

Nasdaq

County of HQ

United States

Next Earnings Date

05/21/26

Business Summary

Applied Digital operates in technology infrastructure and digital services, providing capacity and technical environments that support compute-intensive workloads. The business model revolves around deploying and operating specialized facilities and services that customers rely on for high-performance processing needs. Cash generation ultimately depends on maintaining utilization rates and controlling infrastructure costs while scaling revenue per deployment. The moat, if it develops, comes from capital intensity, long-term service relationships, and operational expertise in managing complex digital infrastructure environments — but that moat only matters if it translates into sustained positive margins.

VALUATION

P/E

-

Market Cap ($M USD)

$436

Forward P/E

-

PEG

-

PRICE TO SALES

-

PRICE TO BOOK

3.2

EV / EBITDA

-2.8

5-Year Average P/E

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

-

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

-$1.76

Next Year EPS Growth Estimate

-$1.63

Next Year Revenue Growth Estimate

-

Return on Equity (ROE)

-77.60%

Operating Margin

-

Debt-to-Equity

0.1

Piotroski F-Score

2

Altman Z-Score

2.8

Return on Invested Capital (ROIC)

-69.40%%

Current Ratio

8.2

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At a $7,504M market cap with no P/E, no Forward P/E, and a deeply distressed Altman Z-Score of 1.1, this is not a stable compounder — it is a speculative restructuring story. The absence of earnings, an EPS of -413.2, and estimated EPS next year of -$0.38 signal a company still searching for a sustainable profit model. A Price/Sales ratio of 21.4 and Price/Book of 4.8 are aggressive multiples for a business with a -12.20% operating margin and -4.10% ROIC. The market is not pricing in safety; it is pricing in optionality. This is a high-volatility asset where solvency risk is real and valuation support is thin.

AI Exposure / Tech Reliance

Operating in Information Technology Services, the company sits in a sector that is structurally leveraged to AI infrastructure, cloud migration, and digital transformation trends. Technology services firms that adapt to AI workloads and infrastructure scaling can experience nonlinear demand growth. However, adaptation requires capital discipline and execution — something not yet reflected in current profitability metrics.

The Bull Case

A value-oriented or GARP investor could argue that the setup reflects early-stage operating leverage. Institutional ownership at 49.15% suggests serious capital is willing to underwrite the story, while a Piotroski F-Score of 5 indicates middling but not collapsing financial quality. Return on Equity of 32.90% stands out as a strong capital efficiency signal, and a current ratio of 2.4 implies near-term liquidity is manageable. If operating margins recover from -12.20% toward breakeven, the revenue base implied by a 21.4 Price/Sales multiple could convert into meaningful earnings torque. In that scenario, today’s lack of earnings becomes irrelevant, and the stock transitions from speculative to scalable.

The Bear Case

The structural risks are severe. An Altman Z-Score of 1.1 places the company squarely in financial distress territory, while negative earnings and negative ROIC (-4.10%) confirm capital is currently being destroyed, not compounded. Sales Growth Next Year listed at -$0.89 signals contraction rather than expansion, undermining the premium 21.4 Price/Sales multiple. Operating margin at -12.20% means the core business model is not self-funding, and the absence of a P/E or Forward P/E removes any earnings-based valuation anchor. This is a balance sheet and execution gamble, not a proven growth story.

Market Sentiment & Smart Money

Short Interest %

4.50%

Analyst Consensus

1.29

Average Analyst Price Target

$20.20

Institutional Ownership %

84.60%

1-Year Beta

1.68

Insider Buying % (6 Mo)

2.00%%

Distance to 52-Week High

90.90%%

Distance to 52-Week Low

156.50%%